Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Abdel G, Babiker"'
Autor:
Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu, Vivian Kwaghe, Roger Paredes, Lourdes Mateu, Srikanth Ramachandruni, Rajeev Narang, Mamta K. Jain, Susana M. Lazarte, Jason V. Baker, Anne E.P. Frosch, Garyfallia Poulakou, Konstantinos N. Syrigos, Gretchen S. Arnoczy, Natalie A. McBride, Philip A. Robinson, Farjad Sarafian, Sanjay Bhagani, Hassan S. Taha, Thomas Benfield, Sean T.H. Liu, Anastasia Antoniadou, Jens Ulrik Stæhr Jensen, Ioannis Kalomenidis, Adityo Susilo, Prasetyo Hariadi, Tomas O. Jensen MD, Jose Luis Morales-Rull, Marie Helleberg, Sreenath Meegada, Isik S. Johansen, Daniel Canario, Eduardo Fernández-Cruz, Simeon Metallidis, Amish Shah, Aki Sakurai, Nikolaos G. Koulouris, Robin Trotman, Amy C. Weintrob, Daria Podlekareva, Usman Hadi, Kathryn M. Lloyd, Birgit Thorup Røge, Sho Saito, Kelly Sweerus, Jakob J. Malin, Christoph Lübbert, Jose Muñoz, Matthew J. Cummings, Marcelo H. Losso, Dan Turner, Kathryn Shaw-Saliba, Robin Dewar, Helene Highbarger, Perrine Lallemand, Tauseef Rehman, Norman Gerry, Dona Arlinda, Christina C. Chang, Birgit Grund, Michael R. Holbrook, Horace P. Holley, Fleur Hudson, Laura A. McNay, Daniel D. Murray, Sarah L. Pett, Megan Shaughnessy, Mary C. Smolskis, Giota Touloumi, Mary E. Wright, Mittie K. Doyle, Sharon Popik, Christine Hall, Roshan Ramanathan, Huyen Cao, Elsa Mondou, Todd Willis, Joseph V. Thakuria, Leman Yel, Elizabeth Higgs, Virginia L. Kan, Jens D. Lundgren, James D. Neaton, H. Clifford Lane
Publikováno v:
Lancet (London, England)
Background Passive immunotherapy using hyperimmune intravenous immunoglobulin (hIVIG) to SARS-CoV-2, derived from recovered donors, is a potential rapidly available, specific therapy for an outbreak infection such as SARS-CoV-2. Findings from randomi
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19:A Randomized Controlled Trial
Autor:
Christina, Barkauskas, Eleftherios, Mylonakis, Garyfallia, Poulakou, Barnaby E, Young, David M, Vock, Lianne, Siegel, Nicole, Engen, Greg, Grandits, Nilima R, Mosaly, Andrew M, Vekstein, Ralph, Rogers, Fadi, Shehadeh, Matthew, Kaczynski, Evangelia K, Mylona, Konstantinos N, Syrigos, Vasiliki, Rapti, David C, Lye, Diong Shiau, Hui, Lindsay, Leither, Kirk U, Knowlton, Mamta K, Jain, Rubria, Marines-Price, Alice, Osuji, J Scott, Overcash, Ioannis, Kalomenidis, Zafeiria, Barmparessou, Michael, Waters, Karla, Zepeda, Peter, Chen, Sam, Torbati, Francis, Kiweewa, Nicholus, Sebudde, Eyad, Almasri, Alyssa, Hughes, Sanjay R, Bhagani, Alison, Rodger, Uriel, Sandkovsky, Robert L, Gottlieb, Eriobu, Nnakelu, Barbara, Trautner, Vidya, Menon, Joseph, Lutaakome, Michael, Matthay, Philip, Robinson, Konstantinos, Protopapas, Nikolaos, Koulouris, Ivan, Kimuli, Amiran, Baduashvili, Dominique L, Braun, Huldrych F, Günthard, Srikanth, Ramachandruni, Robert, Kidega, Kami, Kim, Timothy J, Hatlen, Andrew N, Phillips, Daniel D, Murray, Tomas O, Jensen, Maria L, Padilla, Evan X, Accardi, Katy, Shaw-Saliba, Robin L, Dewar, Marc, Teitelbaum, Ven, Natarajan, Sylvain, Laverdure, Helene C, Highbarger, M Tauseef, Rehman, Susan, Vogel, David, Vallée, Page, Crew, Negin, Atri, Adam J, Schechner, Sarah, Pett, Fleur, Hudson, Jonathan, Badrock, Giota, Touloumi, Samuel M, Brown, Wesley H, Self, Crystal M, North, Adit A, Ginde, Christina C, Chang, Anthony, Kelleher, Stephanie, Nagy-Agren, Shikha, Vasudeva, David, Looney, Hien H, Nguyen, Adriana, Sánchez, Amy C, Weintrob, Birgit, Grund, Shweta, Sharma, Cavan S, Reilly, Roger, Paredes, Agnieszka, Bednarska, Norman P, Gerry, Abdel G, Babiker, Victoria J, Davey, Annetine C, Gelijns, Elizabeth S, Higgs, Virginia, Kan, Gail, Matthews, B Taylor, Thompson, Philippe, Legenne, Richa, Chandra, H Clifford, Lane, James D, Neaton, Richard, Williams
Publikováno v:
ACTIV-3/TICO Study Group*, Nielsen, H, Thisted, R K, Petersen, K T & Juhl, M R 2022, ' Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 9, pp. 1266-1274 . https://doi.org/10.7326/M22-1503
BACKGROUND: Ensovibep (MP0420) is a designed ankyrin repeat protein, a novel class of engineered proteins, under investigation as a treatment of SARS-CoV-2 infection. OBJECTIVE: To investigate if ensovibep, in addition to remdesivir and other standar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d142eddc0f692abd7c33d99b51bb4e
https://vbn.aau.dk/da/publications/828dfc6c-d4d0-47b8-a749-9cc4901459a8
https://vbn.aau.dk/da/publications/828dfc6c-d4d0-47b8-a749-9cc4901459a8
Autor:
Angela J, Rogers, Deborah, Wentworth, Andrew, Phillips, Katy, Shaw-Saliba, Robin L, Dewar, Neil R, Aggarwal, Abdel G, Babiker, Weizhong, Chang, Nila J, Dharan, Victoria J, Davey, Elizabeth S, Higgs, Norman, Gerry, Adit A, Ginde, J W Awori, Hayanga, Helene, Highbarger, Jeroen L, Highbarger, Mamta K, Jain, Virginia, Kan, Kami, Kim, Perrine, Lallemand, Bradley G, Leshnower, Joseph K, Lutaakome, Gail, Matthews, Ahmad, Mourad, Eleftherios, Mylonakis, Ven, Natarajan, Maria L, Padilla, Lavannya M, Pandit, Roger, Paredes, Sarah, Pett, Srikanth, Ramachandruni, M Tauseef, Rehman, Brad T, Sherman, D Clark, Files, Samuel M, Brown, Michael A, Matthay, B Taylor, Thompson, James D, Neaton, H Clifford, Lane, Richard, Williams
Publikováno v:
ACTIV-3/TICO Study Group*, Nielsen, H, Thisted, R K, Petersen, K T & Juhl, M R 2022, ' The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 ', Annals of Internal Medicine, vol. 175, no. 10, pp. 1401-1410 . https://doi.org/10.7326/M22-0924
Background: Levels of plasma SARS-CoV-2 nucleocapsid (N) antigen may be an important biomarker in patients with COVID-19 and enhance our understanding of the pathogenesis of COVID-19. Objective: To evaluate whether levels of plasma antigen can predic
Autor:
Jens D, Lundgren, Birgit, Grund, Christina E, Barkauskas, Thomas L, Holland, Robert L, Gottlieb, Uriel, Sandkovsky, Samuel M, Brown, Kirk U, Knowlton, Wesley H, Self, D Clark, Files, Mamta K, Jain, Thomas, Benfield, Michael E, Bowdish, Bradley G, Leshnower, Jason V, Baker, Jens-Ulrik, Jensen, Edward M, Gardner, Adit A, Ginde, Estelle S, Harris, Isik S, Johansen, Norman, Markowitz, Michael A, Matthay, Lars, Østergaard, Christina C, Chang, Anna L, Goodman, Weizhong, Chang, Robin L, Dewar, Norman P, Gerry, Elizabeth S, Higgs, Helene, Highbarger, Daniel D, Murray, Thomas A, Murray, Ven, Natarajan, Roger, Paredes, Mahesh K B, Parmar, Andrew N, Phillips, Cavan, Reilly, Adam W, Rupert, Shweta, Sharma, Kathryn, Shaw-Saliba, Brad T, Sherman, Marc, Teitelbaum, Deborah, Wentworth, Huyen, Cao, Paul, Klekotka, Abdel G, Babiker, Victoria J, Davey, Annetine C, Gelijns, Virginia L, Kan, Mark N, Polizzotto, B Taylor, Thompson, H Clifford, Lane, Christine, Wenner
Publikováno v:
ACTIV-3/TICO Bamlanivimab Study Group & Nielsen, H 2022, ' Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 2, pp. 234–243 . https://doi.org/10.7326/M21-3507
Ann Intern Med
Annals of Internal Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
ACTIV-3/TICO Bamlanivimab Study Group & Østergaard, L J 2022, ' Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 2, pp. 234-243 . https://doi.org/10.7326/M21-3507
ACTIV-3/TICO Bamlanivimab Study Group* & Johansen, I S 2022, ' Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 2, pp. 234-243 . https://doi.org/10.7326/M21-3507
Ann Intern Med
Annals of Internal Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
ACTIV-3/TICO Bamlanivimab Study Group & Østergaard, L J 2022, ' Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 2, pp. 234-243 . https://doi.org/10.7326/M21-3507
ACTIV-3/TICO Bamlanivimab Study Group* & Johansen, I S 2022, ' Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 2, pp. 234-243 . https://doi.org/10.7326/M21-3507
BACKGROUND: In a randomized, placebo-controlled, clinical trial, bamlanivimab, a SARS-CoV-2-neutralizing monoclonal antibody, given in combination with remdesivir, did not improve outcomes among hospitalized patients with COVID-19 based on an early f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c47486ea46158d87443ce42801dba2f
https://vbn.aau.dk/da/publications/c530ec33-9c51-477d-98fa-36df01391484
https://vbn.aau.dk/da/publications/c530ec33-9c51-477d-98fa-36df01391484
Autor:
Eleftherios Mylonakis, Joseph Lutaakome, Mamta K. Jain, Angela J. Rogers, José Moltó, Susana Benet, Ahmad Mourad, D. Clark Files, Henry Mugerwa, Cissy Kityo, Francis Kiweewa, Mary Grace Nalubega, Jonathan Kitonsa, Evelyn Nabenkema, Daniel D. Murray, Dominique Braun, Dena Kamel, Elizabeth S. Higgs, Timothy J. Hatlen, Virginia L. Kan, Adriana Sanchez, John Tierney, Eileen Denner, Deborah Wentworth, Abdel G. Babiker, Victoria J. Davey, Annetine C. Gelijns, Gail V. Matthews, B. Taylor Thompson, H. Clifford Lane, James D. Neaton, Jens D. Lundgren
Publikováno v:
Mylonakis, E, Lutaakome, J, Jain, M K, Rogers, A J, Molto, J, Benet, S, Mourad, A, Files, D C, Mugerwa, H, Kityo, C, Kiweewa, F, Nalubega, M G, Kitonsa, J, Nabenkema, E, Murray, D D, Braun, D, Kamel, D, Higgs, E S, Hatlen, T J, Kan, V L, Sanchez, A, Tierney, J, Denner, E, Wentworth, D, Babiker, A G, Davey, V J, Gelijns, A C, Matthews, G, Thompson, B T, Lane, H C, Neaton, J D & Lundgren, J D 2022, ' Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO) ', Med, vol. 3, no. 8, pp. 531-537 . https://doi.org/10.1016/j.medj.2022.07.003
The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0dfa0b3688e584e03b2edc2298e07e
https://curis.ku.dk/ws/files/345513460/PIIS2666634022003130.pdf
https://curis.ku.dk/ws/files/345513460/PIIS2666634022003130.pdf
Autor:
Avy, Violari, Mark F, Cotton, Diana M, Gibb, Abdel G, Babiker, Jan, Steyn, Shabir A, Madhi, Patrick, Jean-Philippe, James A, McIntyre, P, Mwaba
Publikováno v:
New England Journal of Medicine. 359:2233-2244
In countries with a high seroprevalence of human immunodeficiency virus type 1 (HIV-1), HIV infection contributes significantly to infant mortality. We investigated antiretroviral-treatment strategies in the Children with HIV Early Antiretroviral The
Autor:
Mark F, Cotton, Avy, Violari, Kennedy, Otwombe, Ravindre, Panchia, Els, Dobbels, Helena, Rabie, Deirdre, Josipovic, Afaaf, Liberty, Erica, Lazarus, Steve, Innes, Anita Janse, van Rensburg, Wilma, Pelser, Handre, Truter, Shabir A, Madhi, Edward, Handelsman, Patrick, Jean-Philippe, James A, McIntyre, Diana M, Gibb, Abdel G, Babiker, Rebecca, DerSimonian
Publikováno v:
Lancet (London, England). 382(9904)
Summary Background Interim results from the children with HIV early antiretroviral (CHER) trial showed that early antiretroviral therapy (ART) was life-saving for infants infected with HIV. In view of the few treatment options and the potential toxic
Autor:
Kathryn, Maitland, Elizabeth C, George, Jennifer A, Evans, Sarah, Kiguli, Peter, Olupot-Olupot, Samuel O, Akech, Robert O, Opoka, Charles, Engoru, Richard, Nyeko, George, Mtove, Hugh, Reyburn, Bernadette, Brent, Julius, Nteziyaremye, Ayub, Mpoya, Natalie, Prevatt, Cornelius M, Dambisya, Daniel, Semakula, Ahmed, Ddungu, Vicent, Okuuny, Ronald, Wokulira, Molline, Timbwa, Benedict, Otii, Michael, Levin, Jane, Crawley, Abdel G, Babiker, Diana M, Gibb
Publikováno v:
BMC Medicine
Early rapid fluid resuscitation (boluses) in African children with severe febrileillnesses increases the 48-hour mortality by 3.3% compared with controls (nobolus). We explored the effect of boluses on 48-hour all-cause mortality byclinical presentat